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We would like to revisit the commentary by Christaki 
and Patrozou [1] on regulatory T cells (Tregs) as signiﬁ  -
cant modulators of various immune responses after 
severe injury. Indeed, we would like to add some very 
recent references that strongly reinforce their results.
Strong evidence indicates that, in septic conditions, 
increases in Tregs have deleterious consequences. In 
septic shock patients, augmented levels of Tregs 
signiﬁ   cantly and inversely correlated with decreased 
lymphocyte proliferation [2]. Th  is phenomenon, recapi-
tu  lated after cecal ligation and puncture (CLP) in mice, 
was totally abrogated by using Foxp3 small interfering 
RNA (Foxp3 is a speciﬁ  c Treg transcription factor). In a 
similar model [3], after mild CLP, mice presented with 
immunosuppression that dampened defenses against 
secondary infectious challenge (Legionella pneumo  philia
inoculation 15 days after CLP). Th  e restoration of 
eﬃ   cient responses against infection was achieved thanks 
to anti-glucocorticoid-induced TNF receptor antibodies, 
known to abrogate Treg-mediated suppression. Lastly, a 
recent paper published in Blood [4] reported that sepsis-
induced immunosuppression resulted in a reduced 
immune tolerance that facilitated the rapid growth of 
solid tumors. Foxp3+ Tregs were responsible for this 
eﬀ  ect. Although tumors were sub  cutaneously implanted 
(which is not relevant to septic patients), this indicates 
the occurrence of a major immunosuppressive state 
induced by sepsis and driven by Tregs in this model.
Collectively, and beyond Tregs (unfortunately not the 
sole bad guys in the game), these data highlight the 
profound impact of sepsis/injury on immune functions. 
Th   is should stimulate basic research and development of 
innovative therapies for rebalancing immune homeo-
stasis in severe critical illness.
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